Executive Committee

Quynh-Thu Le, MD

Department of Radiation Oncology at Stanford University. She co-directs the Radiation Biology Program of the Stanford Cancer Institute. Her clinical focus is on radiation management of head and neck cancer (HNC). She has led multicenter phase II and III clinical trials, testing the addition of novel drugs as well as radiosensitizer or radioprotector with chemoradiotherapy in HNC. Her lab works on approaches to regenerate salivary glands after radiation damage, identification of biomarkers of prognosis and treatment resistance in HNC, and development of novel treatment strategies for HNC with a focus on the tumor microenvironment and Galectin-1. Dr. Le previously chaired NRG's HNC Committee and currently serves as Group Chair of NRG Oncology as well as Chairperson of NRG's Board of Directors. She has served as a reviewer for several journals and NIH study sections. She has been actively involved in many national and international organizations such as ASTRO, ASCO, AARC, and ARS. She was inducted into the Fellowship of the American College of Radiology (FACR), the American Society of Therapeutic Radiology and Oncology (FASTRO), and the Institute of Medicine / National Academy of Medicine (IOM/NAM).

Robert Mannel, MD

Robert Mannel, MD, is a board-certified gynecologic oncologist, and has served as Director, Stephenson Cancer Center at the University of Oklahoma since 2007. Dr. Mannel has served in multiple national leadership positions in his field including serving as a committee member of the American Board of Obstetrics and Gynecology Gynecologic Oncology Board and was Vice President for the Society of Gynecologic Oncology in 2012-2013. A graduate of the University of Texas College of Medicine at Galveston, Dr. Mannel completed his residency in obstetrics and gynecology at Scott and White Hospital in Temple Texas. After residency, he pursued a gynecologic oncology fellowship at the University of California, Irvine. His research interests lie in drug development in ovarian, endometrial, and cervical cancer. Dr. Mannel served as one of the inaugural Deputy Group Chairs for NRG Oncology. He was appointed as NRG Oncology Group Chair in 2017, and the NRG Oncology Presiding Group Chair in 2022. Dr. Mannel has served as the Senior Vice President of the GOG Foundation since 2017.

Norman Wolmark, MD

Norman Wolmark, MD, FACS, FRCSC, is the Chairman of the NSABP Foundation, a leading academic research organization with a nearly 60-year history of pioneering studies in breast and colorectal cancer. He also serves as Group Chair and Principal Investigator for NRG Oncology. Dr. Wolmark is Professor and Chairman of Human Oncology at Drexel University School of Medicine and a Professor in the Department of Surgery at the University of Pittsburgh School of Medicine and the University of Pittsburgh Hillman Cancer Center. Dr. Wolmark has spent decades advancing research in breast and bowel cancers, contributing to early clinical trials at the University of Pittsburgh alongside Dr. Bernard Fisher. A specialist in general surgery, he is certified by the Royal College of Physicians and Surgeons of Canada and completed his medical degree at McGill University, with residencies at McGill and the University of Pittsburgh. He later completed a fellowship in Surgical Oncology at Memorial Sloan Kettering Cancer Center. During his near 45-year tenure as a cancer researcher, he has published over 400 scientific articles and book chapters, received numerous awards such as the William L. McGuire Memorial Award, and continues to serve on advisory boards and editorial boards in oncology across the globe.